Effects of vanadate on the activities of mice glucokinase and hexokinase

Ming-zhi Xu1, Ai-zhen Zhang, Xiang-rong Li

  • 1Department of Endocrinology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. xu921@21cn.com

Insights

Sodium metavanadate (SMV) enhances glucose phosphorylation in diabetic mice by increasing liver and muscle enzyme activity. This improves blood glucose levels independently of insulin secretion, suggesting a novel hypoglycemic mechanism.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Diabetes Research

Background:

  • Diabetes mellitus is characterized by impaired glucose metabolism.
  • Understanding the mechanisms of hypoglycemic agents is crucial for effective treatment.
  • Sodium metavanadate (SMV) has shown potential as a hypoglycemic agent.

Purpose of the Study:

  • To investigate the hypoglycemic mechanisms of sodium metavanadate (SMV).
  • To determine the effect of SMV on glucose-metabolizing enzymes in diabetic models.
  • To elucidate the relationship between SMV, glucose phosphorylation, and insulin levels.

Main Methods:

  • Oral administration of SMV to diabetic mice.
  • Measurement of liver glucokinase and muscle hexokinase activities.
  • Monitoring of blood glucose levels and insulin levels.

Main Results:

  • Oral SMV administration led to a rapid increase in liver glucokinase and muscle hexokinase activities.
  • Blood glucose levels showed a close correlation with the activities of these two enzymes.
  • No significant correlation was observed between blood glucose levels and insulin levels after SMV treatment.

Conclusions:

  • SMV improves altered glucose phosphorylation in diabetic mice.
  • The hypoglycemic effect of SMV appears to be independent of insulin secretion stimulation.
  • Enhanced glucose phosphorylation by key enzymes is a likely mechanism underlying SMV's hypoglycemic action.

Related Concept Videos